53 related articles for article (PubMed ID: 38570882)
1. Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.
Yao X; Wang W; He Y
Diagn Pathol; 2024 Apr; 19(1):56. PubMed ID: 38570882
[TBL] [Abstract][Full Text] [Related]
2. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
[TBL] [Abstract][Full Text] [Related]
3. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
[TBL] [Abstract][Full Text] [Related]
4. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
[TBL] [Abstract][Full Text] [Related]
5. DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis.
Han LM; Weiel JJ; Longacre TA; Folkins AK
Adv Anat Pathol; 2022 Sep; 29(5):297-308. PubMed ID: 35778792
[TBL] [Abstract][Full Text] [Related]
6. Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review.
Dondi G; Porcu E; De Palma A; Damiano G; De Crescenzo E; Cipriani L; Dirodi M; Ravegnini G; De Leo A; Nannini M; Ferioli M; Morganti AG; Pantaleo MA; De Iaco P; Perrone AM
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830960
[TBL] [Abstract][Full Text] [Related]
7. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk.
Caroleo AM; De Ioris MA; Boccuto L; Alessi I; Del Baldo G; Cacchione A; Agolini E; Rinelli M; Serra A; Carai A; Mastronuzzi A
Front Oncol; 2020; 10():614541. PubMed ID: 33552988
[TBL] [Abstract][Full Text] [Related]
8. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
Apellaniz-Ruiz M; McCluggage WG; Foulkes WD
Genes Chromosomes Cancer; 2021 Mar; 60(3):217-233. PubMed ID: 33135284
[TBL] [Abstract][Full Text] [Related]
9. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.
de Kock L; Yoon JY; Apellaniz-Ruiz M; Pelletier D; McCluggage WG; Stewart CJR; Dickson BC; Rouzbahman M; Clarke BA; Foulkes WD
Mod Pathol; 2020 Jun; 33(6):1207-1219. PubMed ID: 31900434
[TBL] [Abstract][Full Text] [Related]
10. Expanding the spectrum of dicer1-associated sarcomas.
Warren M; Hiemenz MC; Schmidt R; Shows J; Cotter J; Toll S; Parham DM; Biegel JA; Mascarenhas L; Shah R
Mod Pathol; 2020 Jan; 33(1):164-174. PubMed ID: 31537896
[TBL] [Abstract][Full Text] [Related]
11. Uterine and Cervical Adenosarcoma: A Retrospective Study of Overall Oncologic Outcomes and Fertility Preservation in Early-Stage Disease.
Yuan Z; Cao D; Yu M; Shen K; He Y
Oncologist; 2019 Sep; 24(9):e870-e879. PubMed ID: 31127022
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
